Track topics on Twitter Track topics that are important to you
Plant Activators Market by Crop Type Fruits Vegetables, Cereals Grains, Oilseeds Pulses, Turf Ornamentals, Mode of Application Foliar Spray, Soil Treatment, Source Biological, Chemical, Form, and Region Global Forecast to 2023 [Report Updated: 170520
The plant activators market is projected to grow at a CAGR of 6.6%.The plant activators market is estimated at USD 636.76 million in 2018 and projected to grow at a CAGR of 6.6%, to reach USD 878.38 million by 2023. The market is driven by factors such as an increase in crop production, ease of application, increase in need for food security for the increasing population, and rise in consumer dema...
The organic preservative comprises a naturally-occurring substance known as "flavonoids"
"Things are going to unfortunately be ugly on the drug-shortage front for a long time," said Erin Fox, of the University of Utah Health Care.
State-of-the-art facility to support development of innovative, on-trend, nutritious products to meet growing food and beverage demand in Asia-Pacific Archer Daniels Midland Company (NYSE: ADM) today celebrated the opening of its new regional office and state-of-the-art flavor and ingredient creation, application, development and cu...
On the heels of a new plant opening and licensing deal, Chief Technology Officer Knut Niss discussed lessons learned and the road ahead for Mustang.
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Dami Oil Palm Research Station: Head of Plant Pathology . Not disclosed: Dami Oil Palm Research Station: Based in the heart of the oil palm basin of Papua … Continue reading → Cet article #jobs #lifescience Dami Oil Palm Research Station: Head of Plant Pathology es...
15th August 2018: Norwich, UK: Leaf Expression Systems, a contract biopharmaceutical development business specialising in plant-based expression of proteins, metabolites and complex natural products, announced today that life sciences veteran Simon J.Y Saxby has joined the company as Chief Executive Officer. The appointment comes as Leaf Expression System’s multi-million pound purpose-b...
Cambridge, UK, 15 August 2018 – Crescendo Biologics Ltd (Crescendo), the developer of targeted T-cell engagers, today announced that it has achieved another technical milestone in its collaboration with Takeda Pharmaceutical Company Limited (Takeda; TSE:4502). Crescendo’s global, strategic, multi-target collaboration and license agreement with Takeda was announced in October 201...
Crescendo Biologics Ltd (Crescendo), the developer of targeted T-cell engagers, today announced that it has achieved another technical milestone in its collaboration with Takeda Pharmaceutical Company Limited (Takeda; TSE:4502). Crescendo’s global, strategic, multi-target collaboration and license agreement with
Manufacturing delays at a Pfizer-owned EpiPen plant have created an opportunity for Kaléo.
In a second quarter call with investors, president of Mylan, Rajiv Malik, stated the company has undertaken a restructuring and remediation plan at its Morgantown, West Virginia plant.
The post Inari Secures $40 Million in Series B Funding to Expand its Development of Transformational Plant Breeding Technologies appeared first on SynBioBeta.
SummaryZeria Pharmaceutical Co Ltd Zeria, formerly Zeria Yakusho Kenkyusho Co Ltd is a manufacturer of pharmaceutical and nonpharmaceuticals, veterinary pharmaceuticals, industrial chemicals and reagents. The company also manufactures, imports and exports healthcare products such as cosmetics, health foods, alcoholic beverages, soft drinks, food additives, livestock feed, hygienic goods, among oth...
Hydro-Organics, manufacturer of Earth Juice products, announced today a strategic national distribution partnership with Hydrofarm LLC, a leading independent wholesaler and manufacturer of hydroponics equipment and horticultural products. Earth Juice products have provided growers with high-quality and affordable plant nutrients, growing media, and plant p...
SummaryOpen Monoclonal Technology Inc OMT, a subsidiary of Ligand Pharmaceuticals Inc is a biotechnology company that discovers and develops human monoclonal antibody platform based on transgenic rats. The company's products include omnirat, omnimouse and omniflic. Its omnirat is an antibody platform that generates human monoclonal antibodies based on transgenic rats. OMT's omnimouse is a transgen...
NewsAn Idaho-based company that produces potatoes and other crops for 40 countries signed an intellectual property licensing agreement for agricultural use of the CRISP-Cas9 gene editing tool.
Janssen has confirmed plans to close a supply chain facility in HyangNam, while Bayer is transferring manufacturing operations from Ansung, South Korea, to Berlin, Germany.
Celltrion has told shareholders its manufacturing site received a Form 483 from the US FDA.
DAVIS, Calif., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, is pleased to announce its biofumigant in development, Ennoble™, showed powerful results in field trials on strawberries, lettuce and celery, as well ...
Company significantly increases spending and strategic initiatives in support of MRTP application and FDA’s ANPRM for reduced nicotine cigarettes. 22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is focused on tobacco harm reduction, Very Low Nicotine tobacco, and hemp/cannabis research, announced today the Co...